Domesco Medical Import - Export Joint-Stock Corporation (HOSE: DMC)

Market Cap	2.29T
Revenue (ttm)	1.80T
Net Income (ttm)	149.99B
Shares Out	34.73M
EPS (ttm)	4,319.00
PE Ratio	15.24
Forward PE	n/a
Dividend	2,500.00 (3.79%)
Ex-Dividend Date	Sep 13, 2024

Volume	500
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	54,000 - 74,200
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 20, 2025

About DMC

Domesco Medical Import - Export Joint-Stock Corporation manufactures, trades in, and imports pharmaceutical products, materials and sub-materials, medical tools, equipment, and chemicals in Vietnam. The company offers synthetic drug products, including cardiovascular agents, antidiabetics, antibiotics, analgesics and antipyretic drugs, respiratory agents, gastrointestinal drugs, minerals and vitamins, and other synthetic drug products; and herbal, food, dietary supplement, and anti-epidemic products. It also provides pure, mineral, and medical ...

• Industry: Pharmaceutical Preparations
• Founded: 1989
• Employees: 956
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DMC

Financial Performance

In 2023, DMC's revenue was 1.72 trillion, an increase of 7.93% compared to the previous year's 1.59 trillion. Earnings were 155.83 billion, a decrease of -8.37%.